Search

Simple Summary: In recent years, mathematical models have revolutionized cancer research, illuminating the complex dynamics of tumor growth and aiding drug development. These models, reflecting biological and physical processes, are increasingly used in clinical practice, offering precise patient-specific predictions. Our work introduces an innovative in silico model to simulate tumor growth and invasiveness. The automated hybrid cell, replicating key tumor cell features, enables exploration of 3D tumor spheroid evolution. Sensitivity analyses reveal that tumor growth is primarily influenced by cell replication speed and adhesion, while invasiveness relies on chemotaxis. These insights shed light on tumor development mechanisms, guiding effective strategies against tumor progression. Our model serves as a valuable tool for advancing cancer biology research and potential therapeutic interventions. Purpose: In recent years, mathematical models have become instrumental in cancer research, offering insights into tumor growth dynamics, and guiding the development of pharmacological strategies. These models, encompassing diverse biological and physical processes, are increasingly used in clinical settings, showing remarkable predictive precision for individual patient outcomes and therapeutic responses. Methods: Motivated by these advancements, our study introduces an innovative in silico model for simulating tumor growth and invasiveness. The automated hybrid cell emulates critical tumor cell characteristics, including rapid proliferation, heightened motility, reduced cell adhesion, and increased responsiveness to chemotactic signals. This model explores the potential evolution of 3D tumor spheroids by manipulating biological parameters and microenvironment factors, focusing on nutrient availability. Results: Our comprehensive global and local sensitivity analysis reveals that tumor growth primarily depends on cell duplication speed and cell-to-cell adhesion, rather than external chemical gradients. Conversely, tumor invasiveness is predominantly driven by chemotaxis. These insights illuminate tumor development mechanisms, providing vital guidance for effective strategies against tumor progression. Our proposed model is a valuable tool for advancing cancer biology research and exploring potential therapeutic interventions. [ABSTRACT FROM AUTHOR]

Simple Summary: Cell migration is a key factor in the spread of metastatic tumors and a major contributor to cancer-related mortality. However, our comprehension of the underlying mechanisms remains incomplete. In this study, we utilized a wound healing assay to explore the migration and invasion of cancer cells in the context of metastasis. We developed a computational model using cellular automata, rigorously calibrated and validated with in vitro data from both tumor and non-tumor cell lines, offering a potent resource. This novel approach is of immense value to the pharmaceutical sector for discovering compounds that can impede cell migration, evaluating the efficacy of potential drugs to hinder cancer invasion, and assessing immune system responses. It stands as a breakthrough in the quest for more effective cancer therapies. Purpose: Cell migration is a critical driver of metastatic tumor spread, contributing significantly to cancer-related mortality. Yet, our understanding of the underlying mechanisms remains incomplete. Methods: In this study, a wound healing assay was employed to investigate cancer cell migratory behavior, with the aim of utilizing migration as a biomarker for invasiveness. To gain a comprehensive understanding of this complex system, we developed a computational model based on cellular automata (CA) and rigorously calibrated and validated it using in vitro data, including both tumoral and non-tumoral cell lines. Harnessing this CA-based framework, extensive numerical experiments were conducted and supported by local and global sensitivity analyses in order to identify the key biological parameters governing this process. Results: Our analyses led to the formulation of a power law equation derived from just a few input parameters that accurately describes the governing mechanism of wound healing. This groundbreaking research provides a powerful tool for the pharmaceutical industry. In fact, this approach proves invaluable for the discovery of novel compounds aimed at disrupting cell migration, assessing the efficacy of prospective drugs designed to impede cancer invasion, and evaluating the immune system's responses. [ABSTRACT FROM AUTHOR]